Who owns Moderna, Inc. (MRNA)? Elite investor 13F holders
3 tracked elite investors reported holding Moderna, Inc as of 2026-06-30, including D.E. Shaw, Bridgewater Associates, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | MODERNA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | MODERNA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1747319.00 USD | 24951.000000 | Shares | reduce | Original filing |
| Tudor Investment | MODERNA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Bridgewater Associates | MODERNA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 807236.00 USD | 11527.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | MODERNA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8053.00 USD | 115.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.